Fenofibrate/Pitavastatin Calcium

非诺贝特/匹伐他汀钙

Report date: 2022/07/18 15:43:37

Base Information

Drug NameFenofibrate/Pitavastatin Calcium
Drug Alias Name匹伐他汀钙/非诺贝特Pitavastatin/FenofibratePitavastatin Calcium/Fenofibratefenofibrate/pitavastatin
ClassificationSmall molecules
Mechanisms of ActionPeroxisome proliferator activated receptor agonistsHMG-CoA reductase inhibitors
TargetsPeroxisome proliferator activated receptorHMG-CoA reductase
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes Pitavastatin CalciumFenofibrate
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHanmi Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A